← SynDRA

FEVIPIPRANT

SynDRA canonical compound SYN0037862 — structure-anchored drug synonym record

All known targets

• PTGDR2

Mechanisms of action (all sources)

• PTGDR2 ANTAGONIST
• G protein-coupled receptor 44 antagonist
• prostaglandin inhibitor

Cross-references

• PubChem CID: 23582412
• ChEMBL: CHEMBL3137332
• DrugBank: DB12011
• KEGG: D10631
• PDB: FSY
• Wikipedia: Fevipiprant
• TTD: DH7F9S

Synonyms

• NVP-QAW039
• QAW-039
• QAW039
• UNII-2PEX5N7DQ4
• 2PEX5N7DQ4
• 2-[2-methyl-1-[[4-methylsulfonyl-2-(trifluoromethyl)phenyl]methyl]pyrrolo[2,3-b]pyridin-3-yl]acetic acid
• 2-(2-methyl-1-(4-(methylsulfonyl)-2-(trifluoromethyl)benzyl)-1H-pyrrolo[2,3-b]pyridin-3-yl)acetic acid
• 2-Methyl-1-[[4-(methylsulfonyl)-2-(trifluoromethyl)phenyl]methyl]-1H-pyrrolo[2,3-b]pyridine-3-acetic acid
• Fevipiprant [INN]
• Fevipiprant [USAN:INN]
• Fevipiprant (JAN/USAN/INN)
• GTPL8995
• SCHEMBL1940595
• CHEMBL3137332
• HMS3743E19
• BCP25015
• EX-A2495
• BDBM50233520
• ZINC43101772
• AB85348
• CS-5956
• DB12011
• SB16897
• (1-(4-((Methane)sulfonyl)-2-trifluoromethylbenzyl)-2-methyl-1H-pyrrolo(2,3-b)pyridin-3-yl)acetic acid
• 2-(1-((4-Methanesulfonyl-2-(trifluoromethyl)phenyl)methyl(-2-methyl-1H-pyrrolo(2,3-b)pyridin-3-yl)acetic acid
• AC-31956
• AS-74870
• HY-16768
• DS-022511
• FT-0774596
• D10631
• Q27077292
• 1-(4-methanesulfonylbenzyl)-2-methyl-1H-pyrrolo(2,3-b)pyridin-3-yl)acetic acid
• (2-methyl-1-{[4-(methylsulfonyl)-2-(trifluoromethyl)phenyl]methyl}-1H-pyrrolo[2,3-b]pyridin-3-yl)acetic acid
• [1-(4-Methanesulfonyl-2-trifluoromethyl-benzyl)-2-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl]-acetic acid
• [2-METHYL-1-[4-(METHYLSULFONYL)-2-(TRIFLUOROMETHYL)BENZYL]-1H-PYRROLO[2,3-B]PYRIDIN-3-YL]ACETIC ACID
• 2-(1-{[4-methanesulfonyl-2-(trifluoromethyl)phenyl]methyl}-2-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)acetic acid
• 2-[2-methyl-1-[[4-methylsulfonyl-2-(trifluoromethyl)phenyl]methyl]pyrrolo[5,4-b]pyridin-3-yl]acetic acid
• FSY